These results demonstrate that CD11b deficiency suppressed tumor growth by reducing the amount of TNF-α secreted by myeloid cells and inhibiting MDSCs recruitment to the tumor microenvironment, which further prevented the inhibition of IFN-γ production and promoted the production of CXCL9 in CRC. This evidence concerns the gene CXCL9 and neoplasm.